Literature DB >> 27591336

Novel Evasion Mechanisms of the Classical Complement Pathway.

Brandon L Garcia1, Seline A Zwarthoff2, Suzan H M Rooijakkers2, Brian V Geisbrecht3.   

Abstract

Complement is a network of soluble and cell surface-associated proteins that gives rise to a self-amplifying, yet tightly regulated system with fundamental roles in immune surveillance and clearance. Complement becomes activated on the surface of nonself cells by one of three initiating mechanisms known as the classical, lectin, and alternative pathways. Evasion of complement function is a hallmark of invasive pathogens and hematophagous organisms. Although many complement-inhibition strategies hinge on hijacking activities of endogenous complement regulatory proteins, an increasing number of uniquely evolved evasion molecules have been discovered over the past decade. In this review, we focus on several recent investigations that revealed mechanistically distinct inhibitors of the classical pathway. Because the classical pathway is an important and specific mediator of various autoimmune and inflammatory disorders, in-depth knowledge of novel evasion mechanisms could direct future development of therapeutic anti-inflammatory molecules.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27591336      PMCID: PMC5012295          DOI: 10.4049/jimmunol.1600863

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  129 in total

1.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

Review 2.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

3.  A molecular switch governs the interaction between the human complement protease C1s and its substrate, complement C4.

Authors:  Andrew J Perry; Lakshmi C Wijeyewickrema; Pascal G Wilmann; Menachem J Gunzburg; Laura D'Andrea; James A Irving; Siew Siew Pang; Renee C Duncan; Jacqueline A Wilce; James C Whisstock; Robert N Pike
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

4.  Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.

Authors:  H J Müller-Eberhard; K E Fjellström
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein family.

Authors:  Brandon L Garcia; Brady J Summers; Zhuoer Lin; Kasra X Ramyar; Daniel Ricklin; Divya V Kamath; Zheng-Qing Fu; John D Lambris; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

6.  Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3.

Authors:  Y Q Hong; B Ghebrehiwet
Journal:  Clin Immunol Immunopathol       Date:  1992-02

Review 7.  Complement in immune and inflammatory disorders: therapeutic interventions.

Authors:  Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

8.  SALO, a novel classical pathway complement inhibitor from saliva of the sand fly Lutzomyia longipalpis.

Authors:  Viviana P Ferreira; Vladimir Fazito Vale; Michael K Pangburn; Maha Abdeladhim; Antonio Ferreira Mendes-Sousa; Iliano V Coutinho-Abreu; Manoochehr Rasouli; Elizabeth A Brandt; Claudio Meneses; Kolyvan Ferreira Lima; Ricardo Nascimento Araújo; Marcos Horácio Pereira; Michalis Kotsyfakis; Fabiano Oliveira; Shaden Kamhawi; Jose M C Ribeiro; Nelder F Gontijo; Nicolas Collin; Jesus G Valenzuela
Journal:  Sci Rep       Date:  2016-01-13       Impact factor: 4.379

9.  Novel scabies mite serpins inhibit the three pathways of the human complement system.

Authors:  Angela Mika; Simone L Reynolds; Frida C Mohlin; Charlene Willis; Pearl M Swe; Darren A Pickering; Vanja Halilovic; Lakshmi C Wijeyewickrema; Robert N Pike; Anna M Blom; David J Kemp; Katja Fischer
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

Review 10.  Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway.

Authors:  Russell Wallis
Journal:  Immunobiology       Date:  2006-12-18       Impact factor: 3.144

View more
  21 in total

1.  A structurally dynamic N-terminal region drives function of the staphylococcal peroxidase inhibitor (SPIN).

Authors:  Nienke W M de Jong; Nicoleta T Ploscariu; Kasra X Ramyar; Brandon L Garcia; Alvaro I Herrera; Om Prakash; Benjamin B Katz; Kevin G Leidal; William M Nauseef; Kok P M van Kessel; Jos A G van Strijp; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

2.  Identification and structural characterization of a novel myeloperoxidase inhibitor from Staphylococcus delphini.

Authors:  Nicoleta T Ploscariu; Nienke W M de Jong; Kok P M van Kessel; Jos A G van Strijp; Brian V Geisbrecht
Journal:  Arch Biochem Biophys       Date:  2018-03-07       Impact factor: 4.013

3.  Local structural plasticity of the Staphylococcus aureus evasion protein EapH1 enables engagement with multiple neutrophil serine proteases.

Authors:  Timothy J Herdendorf; Daphne A C Stapels; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

4.  The structural basis for inhibition of the classical and lectin complement pathways by S. aureus extracellular adherence protein.

Authors:  Jordan L Woehl; Kasra X Ramyar; Benjamin B Katz; John K Walker; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2017-05-31       Impact factor: 6.725

5.  1H, 15N, and 13C resonance assignments of the third domain from the S. aureus innate immune evasion protein Eap.

Authors:  Alvaro I Herrera; Nicoleta T Ploscariu; Brian V Geisbrecht; Om Prakash
Journal:  Biomol NMR Assign       Date:  2018-01-25       Impact factor: 0.746

6.  Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy.

Authors:  Michela Milani; Andrea Annoni; Sara Bartolaccini; Mauro Biffi; Fabio Russo; Tiziano Di Tomaso; Andrea Raimondi; Johannes Lengler; Michael C Holmes; Friedrich Scheiflinger; Angelo Lombardo; Alessio Cantore; Luigi Naldini
Journal:  EMBO Mol Med       Date:  2017-11       Impact factor: 12.137

Review 7.  Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases.

Authors:  Falguni Baidya; Mariya Bohra; Aishika Datta; Deepaneeta Sarmah; Birva Shah; Priya Jagtap; Swapnil Raut; Ankan Sarkar; Upasna Singh; Kiran Kalia; Anupom Borah; Xin Wang; Kunjan R Dave; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Immunology       Date:  2020-10-06       Impact factor: 7.397

8.  C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases.

Authors:  Seline A Zwarthoff; Kevin Widmer; Annemarie Kuipers; Jürgen Strasser; Maartje Ruyken; Piet C Aerts; Carla J C de Haas; Deniz Ugurlar; Maurits A den Boer; Gestur Vidarsson; Jos A G van Strijp; Piet Gros; Paul W H I Parren; Kok P M van Kessel; Johannes Preiner; Frank J Beurskens; Janine Schuurman; Daniel Ricklin; Suzan H M Rooijakkers
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

Review 9.  Keeping It All Going-Complement Meets Metabolism.

Authors:  Martin Kolev; Claudia Kemper
Journal:  Front Immunol       Date:  2017-01-18       Impact factor: 7.561

Review 10.  Let's Tie the Knot: Marriage of Complement and Adaptive Immunity in Pathogen Evasion, for Better or Worse.

Authors:  Kaila M Bennett; Suzan H M Rooijakkers; Ronald D Gorham
Journal:  Front Microbiol       Date:  2017-01-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.